267 related articles for article (PubMed ID: 17576365)
21. Trichomonas vaginalis antigens in vaginal and urine specimens by immunochromatography, compared to culture and microscopy.
El-Moamly AM; Rashad SM
J Egypt Soc Parasitol; 2008 Aug; 38(2):573-84. PubMed ID: 18853629
[TBL] [Abstract][Full Text] [Related]
22. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
23. The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases.
Alderete JF; Provenzano D
Genitourin Med; 1997 Aug; 73(4):291-6. PubMed ID: 9389953
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the extracellular proteases of Trichomonas vaginalis.
Garber GE; Lemchuk-Favel LT
Parasitol Res; 1994; 80(5):361-5. PubMed ID: 7971921
[TBL] [Abstract][Full Text] [Related]
25. Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis.
Alderete JF; Newton E; Dennis C; Engbring J; Neale KA
Genitourin Med; 1991 Jun; 67(3):220-5. PubMed ID: 2071124
[TBL] [Abstract][Full Text] [Related]
26. Antibody isotypes in urethral swabs of symptomatic and asymptomatic men infected with Trichomonas vaginalis.
Imam NF; Eassa AH; Shoeib EY; Abo-Raia GY
J Egypt Soc Parasitol; 2007 Dec; 37(3):977-88. PubMed ID: 18383797
[TBL] [Abstract][Full Text] [Related]
27. Identification of Trichomonas vaginalis alpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite.
Addis MF; Rappelli P; Pinto De Andrade AM; Rita FM; Colombo MM; Cappuccinelli P; Fiori PL
J Infect Dis; 1999 Nov; 180(5):1727-30. PubMed ID: 10515842
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Trichomonas vaginalis infection in symptomatic and asymptomatic women in Central Vietnam.
Ton Nu PA; Nguyen VQ; Cao NT; Dessì D; Rappelli P; Fiori PL
J Infect Dev Ctries; 2015 Jul; 9(6):655-60. PubMed ID: 26142677
[TBL] [Abstract][Full Text] [Related]
29. Preliminary studies on target antigens for the diagnosis of Trichomonas vaginalis infection.
Deng HY; Lee JC; Chou SC; Wang GR
J Microbiol Immunol Infect; 1999 Mar; 32(1):14-20. PubMed ID: 11561565
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Trichomonas vaginalis infection in and around Surat.
Chakraborty T; Mulla SA; Kosambiya JK; Desai VK
Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
[TBL] [Abstract][Full Text] [Related]
31. Increased sensitivity of Trichomonas vaginalis isolation from vaginal secretions by subsequent blind passage of preliminary negative cultures.
Sakru N; Toz SO; Yetkin AC; Akinci PY; Kirca U
Diagn Microbiol Infect Dis; 2005 May; 52(1):75-6. PubMed ID: 15878448
[TBL] [Abstract][Full Text] [Related]
32. Detection of antitrichomonal antibodies in sera and cervical secretions in trichomoniasis.
Romia SA; Othman TA
J Egypt Soc Parasitol; 1991 Aug; 21(2):373-81. PubMed ID: 1875069
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis.
Brown HL; Fuller DD; Jasper LT; Davis TE; Wright JD
Infect Dis Obstet Gynecol; 2004; 12(1):17-21. PubMed ID: 15460191
[TBL] [Abstract][Full Text] [Related]
34. [Trichomonas vaginitis at different life stages of women].
Soszka S; Kazanowska W; Kuczyńska K; Sipowicz I; Kulikowska E
Wiad Parazytol; 1990; 36(5-6):211-7. PubMed ID: 2131695
[TBL] [Abstract][Full Text] [Related]
35. Comparison between Trichmonas vaginalis symptomatic and asymptomatic isolates effects in intravaginally infected rats.
Helmy MM; El-Gayar EK; Hussein EM; Abdou AM; Mahdy ZE
J Egypt Soc Parasitol; 2008 Dec; 38(3):843-52. PubMed ID: 19209767
[TBL] [Abstract][Full Text] [Related]
36. Cross-reactivity of Trichomonas in cervical p16INK4a immunocytochemistry is dependent on antibody, not antigen.
Ridder R; Trunk MJ; Negri G
Diagn Cytopathol; 2006 Jul; 34(7):512-4; author reply 515. PubMed ID: 16783782
[No Abstract] [Full Text] [Related]
37. Evaluation of an IgG cystatin capture enzyme-linked immunosorbent assay for the detection of anti-cysteine proteinase antibodies in asymptomatic trichomoniasis patients.
Tawfeek GM; Oteifa NM; el-Gozamy BR
J Egypt Soc Parasitol; 2003 Apr; 33(1):67-83. PubMed ID: 12739802
[TBL] [Abstract][Full Text] [Related]
38. Trichomonas vaginalis: random amplified polymorphic DNA analysis of isolates from symptomatic and asymptomatic women in India.
Kaul P; Gupta I; Sehgal R; Malla N
Parasitol Int; 2004 Sep; 53(3):255-62. PubMed ID: 15468533
[TBL] [Abstract][Full Text] [Related]
39. Systemic immune response to Trichomonas vaginalis infection during pregnancy.
Anderson BL; Cosentino LA; Simhan HN; Hillier SL
Sex Transm Dis; 2007 Jun; 34(6):392-6. PubMed ID: 17028509
[TBL] [Abstract][Full Text] [Related]
40. Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice.
Hernández HM; Figueredo M; Garrido N; Sánchez L; Sarracent J
Int J Parasitol; 2005 Nov; 35(13):1333-7. PubMed ID: 16202417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
